Article: MultiPlan (MPLN) Investigation Alert: Did You Lose Money on Your Investment? Contact Johnson Fistel Regarding Investigation

Article - Media, Publications

MultiPlan (MPLN) Investigation Alert: Did You Lose Money on Your Investment? Contact Johnson Fistel Regarding Investigation

PR Newswire, 21 January 2021

Johnson Fistel’s investigation seeks to determine whether the Company issued false or misleading statements or failed to disclose information relevant to investors.

Last November, Muddy Waters Research published a report entitled “MultiPlan: Private Equity Necrophilia Meets The Great 2020 Money Grab” The report described problem’s involving MultiPlan, including that “MPLN is in the process of losing its largest client, UnitedHealthcare (‘UHC’). UHC has formed a competitor to MPLN that offers significantly lower prices and fewer conflicts of interest.” Additionally, the Muddy Waters report claims that Multiplan is already in financial decline, “and its financial statements were engineered to obscure this existing deterioration.”
Continue reading “Article: MultiPlan (MPLN) Investigation Alert: Did You Lose Money on Your Investment? Contact Johnson Fistel Regarding Investigation”

Article: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MultiPlan Corporation – MPLN

Article - Media, Publications

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MultiPlan Corporation – MPLN

GLOBE NEWSWIRE, 19 December 2020

Pomerantz LLP is investigating claims on behalf of investors of MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether MultiPlan and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
Continue reading “Article: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MultiPlan Corporation – MPLN”

Article: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages MultiPlan (MPLN) Investors with Losses to Contact Its Attorneys, Firm Investigating Possible Securities Fraud

Article - Media, Publications

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages MultiPlan (MPLN) Investors with Losses to Contact Its Attorneys, Firm Investigating Possible Securities Fraud

Globe Newswire, 08 December 2020

The investigation centers on MultiPlan’s financial disclosures leading up to- and through- its merger and going public transaction with special purpose acquisition (“SPAC”) company Churchill Capital Corp. III. More specifically, Hagens Berman is investigating the company’s and its sponsor’s statements about MultiPlan’s client base and revenues. On Nov. 11, 2020, Muddy Waters Capital published a scathing report, “MultiPlan: Private Equity Necrophilia Meets The Great 2020 Money Grab,” based in part on its interviews of former MultiPlan executives.

Among other things, Muddy Waters observes: (1) the company and its sponsors concealed the impending loss of MultiPlan’s largest client (“UnitedHealthcare”, or “UHC”) due to UHC’s formation of a competitor (“Naviguard”) that offers significantly lower prices and fewer conflicts of interest; (2) MultiPlan’s financials “have been financially engineered to obscure the decay in its business;” and, (3) “[w]e understand that in 2018, MPLN released revenue reserves, dropping them from approximately 30% to 10% of revenue, which we believe enabled MPLN to show 2018 EBITDA growth amid shrinking sales.”
Continue reading “Article: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages MultiPlan (MPLN) Investors with Losses to Contact Its Attorneys, Firm Investigating Possible Securities Fraud”

Article: INVESTOR ALERT: Kirby McInerney LLP Continues Investigation of Shareholder Claims Against MultiPlan Corporation

Article - Media, Publications

INVESTOR ALERT: Kirby McInerney LLP Continues Investigation of Shareholder Claims Against MultiPlan Corporation

GLOBE NEWSWIRE, 01 December 2020

On November 11, 2020, Muddy Waters Research (“Muddy Waters”) released a report entitled “MultiPlan: Private Equity Necrophilia Meets The Great 2020 Money Grab.” Among other issues, the Muddy Waters report asserted that Multiplan is “in financial decline, and its financial statements were engineered to obscure this existing deterioration” and that the Company “is in the process of losing its largest client, UnitedHealthcare (‘UHC’),” which “has formed a competitor to MPLN that offers significantly lower prices and fewer conflicts of interest.” On this news, Multiplan’s stock price fell $1.72 per share, or 19.7%, to close at $7.01 per share on November 11, 2020.
Continue reading “Article: INVESTOR ALERT: Kirby McInerney LLP Continues Investigation of Shareholder Claims Against MultiPlan Corporation”

Article: MPLN SECURITIES FRAUD INVESTIGATION: Hagens Berman, National Trial Attorneys, Alerts MultiPlan (MPLN) Investors with Losses to Contact Its Attorneys Now, Firm Investigating Possible Securities Fraud

Article - Media, Publications

MPLN SECURITIES FRAUD INVESTIGATION: Hagens Berman, National Trial Attorneys, Alerts MultiPlan (MPLN) Investors with Losses to Contact Its Attorneys Now, Firm Investigating Possible Securities Fraud

Newsfile Corp., 18 November 2020

The investigation centers on MultiPlan’s financial disclosures leading up to- and through- its merger and going public transaction with special purpose acquisition (“SPAC”) company Churchill Capital Corp. III. More specifically, Hagens Berman is investigating the company’s and its sponsor’s statements about MultiPlan’s client base and revenues. On Nov. 11, 2020, Muddy Waters Capital published a scathing report, “MultiPlan: Private Equity Necrophilia Meets The Great 2020 Money Grab,” based in part on its interviews of former MultiPlan executives.

Among other things, Muddy Waters observes: (1) the company and its sponsors concealed the impending loss of MultiPlan’s largest client (“UnitedHealthcare”, or “UHC”) due to UHC’s formation of a competitor (“Naviguard”) that offers significantly lower prices and fewer conflicts of interest; (2) MultiPlan’s financials “have been financially engineered to obscure the decay in its business;” and, (3) “[w]e understand that in 2018, MPLN released revenue reserves, dropping them from approximately 30% to 10% of revenue, which we believe enabled MPLN to show 2018 EBITDA growth amid shrinking sales.”
Continue reading “Article: MPLN SECURITIES FRAUD INVESTIGATION: Hagens Berman, National Trial Attorneys, Alerts MultiPlan (MPLN) Investors with Losses to Contact Its Attorneys Now, Firm Investigating Possible Securities Fraud”